Pediatric Brain Tumor Market Research Report - Global Forecast till 2027

Pediatric Brain Tumor Market Trends, Insights and Analysis By Types (Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, and others), By Diagnosis (Imaging Tests, Brain Or Spinal Cord Tumor Biopsy, and others), By Treatment, By End User- Global Forecast Till 2027

ID: MRFR/Pharma/2458-HCR | February, 2021 | Region : Global

BRIEF TOC
1. Report Prologue
2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation
3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model
4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators
5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others
6. Global Pediatric brain tumor Market by Types

6.1 Gliomas

6.1.1 Astrocytoma

6.1.2 Malignant Gliomas

6.1.3 Others

6.2 Mixed neuronal-glial tumors

6.2.1 Ganglioglioma

6.2.2 Subependymal giant cell tumor

6.2.3 Pleomorphic xanthoastrocytoma

6.2.4 Others

6.3 Embryonal tumors

6.3.1 Primitive Neuroectodermal Tumor (PNET)

6.3.2 Atypical teratoid/Rhabdoid tumor

6.3.3 Others

6.4 Choroid plexus papilloma/Carcinoma

6.5 Tumors arising from non-neuroepithelial tissue

6.5.1 Craniopharyngioma

6.5.2 Pineal region tumors

6.5.3 Other

6.6 Meningeal tumors

6.7 Others
7. Global Pediatric brain tumor Market by Diagnosis

7.1 Physical Exam

7.2 Imaging tests

7.2.1 Magnetic resonance imaging (MRI) scan

7.2.1.1 Magnetic resonance angiography (MRA)

7.2.1.2 Magnetic resonance spectroscopy (MRS)

7.2.1.3 Magnetic resonance perfusion

7.2.1.4 Functional MRI (fMRI)

7.2.1.5 Others

7.2.2. Computed tomography (CT) scan

7.2.3 Positron emission tomography (PET) scan

7.2.4 Angiogram

7.2.5 Others

7.3 Brain or spinal cord tumor biopsy

7.3.1 Stereotactic needle biopsy

7.3.2 Craniotomy

7.3.3 Others

7.4 Lumbar puncture (spinal tap)

7.5 Blood and urine tests

7.6 Others
8. Global Pediatric brain tumor Market by Treatment

8.1 Surgery

8.1.1 Surgical biopsy

8.1.2 Resection (removal)

8.1.3 Shunt placement/revision

8.1.4 Others

8.2 Therapies

8.2.1 Radiation therapy

8.2.2 Chemotherapy

8.2.2.1 Carboplatin

8.2.2.2 Carmustine (BCNU)

8.2.2.3 Cisplatin

8.2.2.4 Cyclophosphamide

8.2.2.5 Etoposide

8.2.2.6 Lomustine (CCNU)

8.2.2.7 Methotrexate

8.2.2.8 Temozolomide

8.2.2.9 Thiotepa

8.2.2.10 Vincristine

8.2.2.11 Others

8.2.3 Targeted therapy

8.2.4 Others

8.4 Others
9. Global Pediatric brain tumor Market by End User

9.1 Hospitals and clinics

9.2 Medical Research centers

9.3 Academic institutes

9.4 Others
10. Global Pediatric brain tumor Market by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 The US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia

10.4.1 China

10.4.2 India

10.4.3 Japan

10.4.4 South Korea

10.4.5 Rest of Asia

10.5 Pacific

10.6 Middle East and Africa

10.6.1 UAE

10.6.2 Saudi Arabia

10.6.3 Egypt

10.6.4 Rest of Middle East and Africa
11. Competitive landscape
12. Company profile
13. Conclusion

13.1 Key findings

13.1.1 From CEO’s viewpoint

13.1.2 Unmet needs of the market

13.2 Key companies to watch

13.3 Prediction of Pediatric brain tumor Market
14. Appendix